Literature DB >> 8361800

Should chloral hydrate be banned?

A D Steinberg1.   

Abstract

OBJECTIVE: Current federal regulations of potentially carcinogenic environmental chemicals are based on the assumption that risks for humans can be extrapolated from the effects of chronic high-dose exposure of rodents. It is assumed that all chemicals induce cancer by a genotoxic mechanism (direct interaction with DNA) and that humans metabolize chemicals by the same pathways as the test rodents. Trichloroethylene, a former medicine, is now regulated because of rodent studies. Its major metabolite, chloral hydrate, widely used as a sedative in both adults and children, is in danger of being banned by comparable studies. This paper assesses the safety of chloral hydrate.
DESIGN: Analysis of the literature regarding the metabolic, toxicologic, and epidemiologic data on trichloroethylene and chloral hydrate.
RESULTS: The dose-response relationship for carcinogenesis of chloral hydrate and other chemicals in its metabolic breakdown pathway is nonlinear in rodents: very high doses given chronically, sufficient to cause cellular necrosis, are necessary for induction of malignancies. In addition, epidemiologic data on people exposed to substantial amounts of trichloroethylene (which is metabolized to chloral hydrate) show no increase in mortality or cancers.
CONCLUSIONS: The assumptions underlying current regulatory practices for environmental chemicals are not applicable to the medicinal use of chloral hydrate. Instead, a threshold model is appropriate. The data do not suggest the need to ban chloral hydrate as a medicine; however, possible modifications in its use are suggested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361800

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Pharmacodynamics of chloral hydrate in former preterm infants.

Authors:  Karel Allegaert; Hans Daniels; Gunnar Naulaers; Dick Tibboel; Hugo Devlieger
Journal:  Eur J Pediatr       Date:  2005-03-30       Impact factor: 3.183

Review 2.  The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.

Authors:  A M Holbrook; R Crowther; A Lotter; C Cheng; D King
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262

3.  Short-term chloral hydrate administration and cancer in humans.

Authors:  Tmirah Haselkorn; Alice S Whittemore; Natalia Udaltsova; Gary D Friedman
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Pediatric procedural sedation and analgesia in the emergency department: surveying the current European practice.

Authors:  Cyril Sahyoun; Aymeric Cantais; Alain Gervaix; Silvia Bressan; Ruth Löllgen; Baruch Krauss
Journal:  Eur J Pediatr       Date:  2021-01-28       Impact factor: 3.183

5.  Efficacy and Safety of Intranasal Dexmedetomidine vs. Oral Chloral Hydrate for Sedation in Children Undergoing Computed Tomography/Magnetic Resonance Imaging: A Meta-Analysis.

Authors:  Xiaoqian Lyu; Yujuan Tao; Xiujing Dang
Journal:  Front Pediatr       Date:  2022-03-31       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.